Clinical Trial Update: Open Label Pilot Trial of Rituximab in Lupus Membranous Nephritis [NA]

View source ↗

Summary

A open-label pilot trial of rituximab for lupus membranous nephritis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• Rituxan (rituximab)

Snippet

Sponsor: Northwell Health | Conditions: Lupus Nephritis | NA | Status: WITHDRAWN